Halbert Hargrove Global Advisors, LLC Abb Vie Inc. Transaction History

Halbert Hargrove Global Advisors, LLC

$1.81 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $64,206 - $73,943	444 Added 13.17%	3,815 $607,000
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $35,407 - $42,462	256 Added 8.22%	3,371 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $17,715 - $20,318	132 Added 4.43%	3,115 $418,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $10,871 - $13,821	-79 Reduced 2.58%	2,983 $457,000
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $21,512 - $26,691	163 Added 5.62%	3,062 $497,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $19,981 - $25,282	186 Added 6.86%	2,899 $393,000
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $2,021 - $2,294	19 Added 0.71%	2,713 $293,000
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $7,154 - $7,970	-68 Reduced 2.46%	2,694 $303,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $28,848 - $31,758	282 Added 11.37%	2,762 $299,000
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $7,888 - $10,649	-98 Reduced 3.8%	2,480 $266,000
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $53,521 - $62,817	-623 Reduced 19.46%	2,578 $226,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $30,228 - $40,450	412 Added 14.77%	3,201 $314,000
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $8,062 - $12,223	125 Added 4.69%	2,789 $212,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $8,367 - $10,469	-116 Reduced 4.17%	2,664 $236,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $5,038 - $6,057	-80 Reduced 2.8%	2,780 $210,000
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $7,095 - $9,069	108 Added 3.92%	2,860 $208,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $23,913 - $28,144	-310 Reduced 10.12%	2,752 $222,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $23,744 - $29,283	305 Added 11.06%	3,062 $282,000
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $14,759 - $16,407	-166 Reduced 5.68%	2,757 $261,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $4,219 - $4,992	47 Added 1.63%	2,923 $271,000
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $9,569 - $12,813	-104 Reduced 3.49%	2,876 $272,000
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $6,000 - $6,580	-67 Reduced 2.2%	2,980 $288,000
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $212,832 - $271,853	3,047	3,047 $271,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account